Genetic Locus in Mice That Blocks Development of Atherosclerosis Despite Extreme Hyperlipidemia
暂无分享,去创建一个
A. Lusis | M. Mehrabian | Xuping Wang | A. Fogelman | J. Wong | Weibin Shi | A M Fogelman | M Mehrabian | A J Lusis | J Wong | X Wang | Z Jiang | W Shi | Zhiming Jiang | Jack Wong
[1] D K Burns,et al. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. , 1994, The Journal of clinical investigation.
[2] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[3] D. Shih,et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.
[4] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[5] D. Shih,et al. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. , 2000, Circulation.
[6] A. Lusis,et al. Effect of Macrophage-Derived Apolipoprotein E on Established Atherosclerosis in Apolipoprotein E–Deficient Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[7] E. Lander,et al. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.
[8] D. Shih,et al. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. , 2000, Circulation research.
[9] B. Spiegelman,et al. Peroxisome proliferator–activated receptor γ ligands and atherosclerosis: ending the heartache , 2000 .
[10] A. Lusis,et al. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. , 1993, The Journal of biological chemistry.
[11] Andrew C. Li,et al. Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice , 2000 .
[12] T. Innerarity,et al. Apolipoprotein B mRNA editing. Direct determination of the edited base and occurrence in non-apolipoprotein B-producing cell lines. , 1990, The Journal of biological chemistry.
[13] J. Todd,et al. The murine type 1 diabetes loci, Idd1, Idd3, Idd5, Idd9, and Idd17/10/18, do not control thymic CD4−CD8−/TCRαβ+ deficiency in the nonobese diabetic mouse , 2001, Mammalian Genome.
[14] A. Lusis,et al. Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. , 1998, The Journal of clinical investigation.
[15] S. Heath,et al. Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[16] A. Lusis,et al. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Daly,et al. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. , 1987, Genomics.
[18] Satoshi Tanaka,et al. PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .
[19] M. Lazar. Progress in cardiovascular biology: PPAR for the course , 2001, Nature Medicine.